send to a friend by email
2024-03-14
Sahem weekly trading report (10-14)-03-2024
In mid-March, Al-Quds Index maintained a relatively narrow price range, to continue to decline in this week as well, closing at 547.09 points; down by 0.26% than the previous week. Whereby, Palestine Stock Exchange PEX is still under the control of several anticipations; the annual financial data disclosures for 2023 anticipation and the dividends distribution for 2023 anticipation. Whereby, the legal granted period to disclose the annual data was postponed to the 17th of March 2023. While the trading was characterized with scarcity and weak price movements coinciding with the routine trading of the Holy month of Ramadan.
In the industry sector, the listed companies continued to raise their recommendation regarding distributing dividends for the shareholders for the year 2023. In this context, the board of directors of Birzeit Pharmaceuticals Company BPC raised a recommendation to the general assembly which will be holding a meeting in the second half of April, to distribute 7% cash dividends for the year 2023. It is good to note that before and in the same sector, the board of directors of Jerusalem Pharmaceuticals Company JPH raised a recommendation to the general assembly, which will be holding a meeting on 22/04/2024, to distribute 10% cash dividends for the year 2023.
Regarding the listed companies annual data disclosures, Beit-Jala Pharmaceuticals Company BJP disclosed posting net income of JD1.87 million in 2023 compared to net income of JD1.98 million in 2022. This mainly resulted from a decline in the company’s sales. Based on the disclosed figures, BJP posts book value of JD2.08 and P/BV of 1.35x. Also, Ramallah Summer Resorts RSR disclosed posting net income of JD0.33 million in 2023 compared to net income of JD0.40 million in 2022. This mainly resulted from a decline in the company’s other revenues. Based on the disclosed figures, RSR posts BV of JD3.27 and P/BV of 1.10x. On the other hand, Palestine Investment & Development Company PID noted realizing net income of JD0.08 in 2023 compared to net loss of JD0.10 million in 2022. This mainly resulted from an increase in the company’s loss from valuation of financial assets through profit or loss. Based on the disclosed figures, PID records BV of JD0.69 and P/BV of 2.27x.
|
|